Sarepta Therapeutics (SRPT) EBIT Margin Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,290.00 |
| Dec 31, 2025 | 66,602.00 |
| Sep 30, 2025 | 58,344.00 |
| Jun 30, 2025 | 55,065.00 |
| Mar 31, 2025 | 66,709.00 |
| Dec 31, 2024 | 25,452.00 |
| Sep 30, 2024 | 12,954.00 |
| Jun 30, 2024 | 29,068.00 |
| Mar 31, 2024 | 9,623.00 |
| Dec 31, 2023 | 17,041.00 |
| Sep 30, 2023 | 8,303.00 |
| Jun 30, 2023 | -45,942.00 |
| Mar 31, 2023 | -689.00 |
| Dec 31, 2022 | -2,273.00 |
| Sep 30, 2022 | 3,668.00 |
| Jun 30, 2022 | 8,094.00 |
| Mar 31, 2022 | -15,468.00 |
| Dec 31, 2019 | 16.54 Mn |
| Sep 30, 2019 | 305,510.00 |
| Jun 30, 2019 | 88,106.00 |
| Mar 31, 2019 | 32,484.00 |
| Dec 31, 2018 | 108,582.00 |
| Sep 30, 2018 | 50,889.00 |
| Jun 30, 2018 | 43,836.00 |
| Mar 31, 2018 | 29,697.00 |
| Dec 31, 2017 | 10,089.00 |
| Sep 30, 2017 | -873.00 |
| Jun 30, 2017 | -13,133.00 |
| Mar 31, 2017 | -17,884.00 |